[Pharmacology of GABA derivatives in correlation with the cerebral dopaminergic system].
D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism; D004569:Electroencephalography; D006018:Glycols / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D006885:Hydroxybutyrates / Q000494:pharmacology*; D006948:Hyperkinesis / Q000188:drug therapy; D007783:Lactones / Q000494:pharmacology; D051379:Mice; D011760:Pyrrolidinones / Q000494:pharmacology; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects
D000613:Aminobutyrates; D006018:Glycols; D006885:Hydroxybutyrates; D007783:Lactones; D011760:Pyrrolidinones; D004298:Dopamine
La pharmacologie des congénères du GABA en corrélation avec le système cérébral dopaminergique